Pfizer Goes On Offense With Celebrex: TV Ads, Study Proposal Stress Safety

Pfizer is positioning Celebrex as the safest choice for pain therapy in its communications to physicians and consumers in the wake of the withdrawal of Merck's Vioxx

More from Archive

More from Pink Sheet